services banner

work with AvanceAvance Shop




rival software


Join our Linked-In discussion group
Join our discussion group "Valuation in Life Sciences"

Categories > Reports

2014-07
Deal Terms in Alzheimer's Disease 2000 - 2014
In this report 21 Alzheimer deals are analyzed. Not only are the publicly available figures displayed, each deal is analyzed how the not disclosed milestones are distributed, what royalty rates are most likely, and what sales assumptions were used at the time of closing the deal.

Excerpt

Price:

 

2009-01
Success Rates in Biotech - Going The Wrong Way
The report "Success Rates in Biotech - Going The Wrong Way" summarizes our review of 211 public biotech companies comprising over 1,500 drug development projects

Content and Figures

Price:


 

Shopping Cart

Checkout

 

 

 

 

 

 

 



Home | About Avance | Services | ri:val | Publications | Book | Contact | Disclaimer-Terms